Sickle cell disease in sub-Saharan Africa: Stakes and strategies for control of the disease

Current Opinion in Hematology

Volumn 21, Issue 3, 2014, Pages 210-214

  Diallo, Dapa A ^a   Guindo, Aldiouma ^a  

^a Centre de Recherche et Lutte Contre la Drépanocytose   (Mali)

Author keywords

control; sickle cell disease; stakes; strategies; sub Saharan Africa

Indexed keywords

AFRICA SOUTH OF THE SAHARA; DISEASE CONTROL; EARLY DIAGNOSIS; EDUCATION PROGRAM; GENETIC COUNSELING; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HOLISTIC CARE; HUMAN; LIFE EXPECTANCY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SICKLE CELL ANEMIA; ANEMIA, SICKLE CELL; COST OF ILLNESS; DISEASE MANAGEMENT; HEALTH CARE DELIVERY; ORGANIZATION AND MANAGEMENT;

AFRICA SOUTH OF THE SAHARA; ANEMIA, SICKLE CELL; COST OF ILLNESS; DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; HEALTH SERVICES ACCESSIBILITY; HUMANS;

EID: 84899492115     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000038     Document Type: Review

References (30)

1. Serjeant GR, Serjeant BE. Management of sickle cell disease; lessons from the Jamaican Cohort Study. Blood 1993; 7:137-145.
2. Nzewi E. Recurrent reincarnation or sickle cell disease? Soc Sci Med 2001; 52:1403-1416.
3. Onwubalili JK. Sickle-cell anaemia: an explanation for the ancient myth of reincarnation in Nigeria. Lancet 1983; 2:503-505.
4. Tchernia G. The long story of the sickle cell disease. Rev Prat 2004; 54:1618-1621.
5. Piel FB, Hay SI, Gupta S, et al. Global burden of sickel cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PloS Med 2013; 10:e1001484.
6. Weatherall D. The inherited disorders of haemoglobin: an increasing neglected health burden. Blood 2010; 115:4331-4336.
7. Ware RE. Is sickle cell anemia a neglected tropical disease? PloS Negl Trop Dis 2013; 7:e2120.
8. WHO World Health Organization. Sickle-cell anaemia. Report A59/9. WHO: Geneva, Switzerland; 2006.
9. Diallo D, Baby M, Boiré A, Diallo YL. Management of vaso-occlusive crisis in sickle cell anemia patients by health workers in Mali. Med Trop 2008; 68:502-506.
10. Bernaudin F, Verlhac S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 2011; 117:1130-1140.
11. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288-294.
12. Makenzie JD, Hernandez A, Pena A, et al. Magnetic resonance imaging in child with sickle cell disease: detecting alterations in the apparent diffusion coefficient in hips with avascular necrosis. Pediatr Radiol 2012; 42:706-7013.
13. Lucarelli G, Isgrò A, Sodani P, Gaziev J. Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. Perspect Med 2012; 2:a011825.
14. Wang WC, Oyeku SO, Luo Z, et al. Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia. Pediatrics 2013; 132:677-683.
15. Jain D, Apte M, Colah R, et al. Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: a single centre experience. Indian Pediatr 2013; 50:929-933.
16. Madadi P, Enato EF, Fulga S, et al. Patterns of paediatric analgesic use in Africa: a systematic review. Arch Dis Child 2012; 97:1086-1091.
17. Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organization challenges. Transfus Med Rev 2012; 26:164-180.
18. Narang S, Fernandez ID, Chin N, et al. Becteremia in children with sickle hemoglobinopathies. J Pedaitr Hematol Oncol 2012; 34:13-16.
19. Marti-carvajal AJ, Agreda-Pé rez LH. Antibiotics for treating osteomylitis in people with sickle cell disease. Cochrane Database Syst Rev 2012; 12:CD007175.
20. Makani J, Komba AN, Cox SE, et al. Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatients clinic and during hospitalization. Blood 2010; 115:215-220.
21. Komba AN, Makani J, Sadarangani M, et al. Malaria as a cause of morbidity and mortality in chlidren with homozygous sickle cell disease on the coast of Kenya. Clin Infect Dis 2009; 49:216-222.
22. Aidoo M, Terlouw DJ, Kolczak MS, et al. Protective effects of sickle cell gene against malaria morbidity and mortality. Lancet 2002; 259:1311-1312.
23. Diallo DA, Thiam MM, Ranque B, Jouven X, the DACDRE Study group [abstract]. Glomé rulopathie dré panocytaire: ré sultats de l'é tude CADRE. VIIème congrè s de la Socié té Africaine Francophone d'Hé matologie (SAFHEMA), Antanarivo, Madagascar. 13-15 Novembre 2013.
24. United Nations Development Programme. Human Development Report 2013. UNDP; 2013.
25. Fassin. Gentilini M. The Bamako initiative [letter]. Lancet 1989; 1:162-163.
26. Ohene-frempong K, Oduro J, Tetteh H, Nkruma F. Screening newborn for sickle cell disease in Ghana. Pediatrics 2008; 121:S120-121.
27. Rahimy MC, Gangbo A, Ahouigan G, Alihonou E. Newborn screening for sickle cell disease in Republic of Benin. J Clin Pathol 2009; 62:46-48.
28. Tshilolo L, Assi LM, Lukusa D, et al. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31204 newborns. J Clin Pathol 2009; 62:35-38.
29. Diallo D. Sickle cell disease in Africa: current situation and strategies for improving the quality and duration of survival. Bull Acad Natl Méd 2008; 192:1361-1373.
30. Diallo DA, Guindo A, Dorie A, et al. Human parvovirus B19 infection in sickle cell anemia patient in Mali: a case-control study. Arch Pediatr 2011; 18:962-965.